Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL STEVIOL GLYCOSIDE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT HYDROGEN STORAGE MARKET SIZE
2.3 VENDOR POSITIONING GRID
2.4 MARKETS COVERED
2.5 GEOGRAPHIC SCOPE
2.6 YEARS CONSIDERED FOR THE STUDY
2.7 RESEARCH METHODOLOGY
2.8 TECHNOLOGY LIFE LINE CURVE
2.9 MULTIVARIATE MODELLING
2.1 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.11 DBMR MARKET POSITION GRID
2.12 MARKET APPLICATION COVERAGE GRID
2.13 DBMR MARKET CHALLENGE MATRIX
2.14 IMPORT AND EXPORT DATA
2.15 SECONDARY SOURCES
2.16 GLOBAL STEVIOL GLYCOSIDE MARKET : RESEARCH SNAPSHOT
2.17 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 KEY PATENTS LAUNCHED
5.2 TECHNOLOGICAL ADVANCEMENT BY MANUFACTURERS
5.3 PORTER’S FIVE FORCES
5.4 VENDOR SELECTION CRITERIA
5.5 PESTEL ANALYSIS
5.6 REGULATION COVERAGE
6 SUPPLY CHAIN ANALYSIS
6.1 OVERVIEW
6.2 LOGISTIC COST SCENARIO
6.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
7 CLIMATE CHANGE SCENARIO
7.1 ENVIRONMENTAL CONCERNS
7.2 INDUSTRY RESPONSE
7.3 GOVERNMENT’S ROLE
7.4 ANALYST RECOMMENDATIONS
8 GLOBAL STEVIOL GLYCOSIDE MARKET, BY PRODUCT TYPE, 2021-2030, (USD MILLION) (MILLION UNITS)
8.1 OVERVIEW
8.2 STEVIOLBIOSIDE
8.3 DULCOSIDE A
8.4 STEVIOSIDE
8.5 REBAUDIOSIDE A
8.6 REBAUDIOSIDE B
8.7 REBAUDIOSIDE C
8.8 REBAUDIOSIDE D
8.9 REBAUDIOSIDE F
8.1 OTHERS
9 GLOBAL STEVIOL GLYCOSIDE MARKET, BY PROCESSING METHOD, 2021-2030, (USD MILLION) (MILLION UNITS)
9.1 OVERVIEW
9.2 FERMENTATION BASED PRODUCTION
9.3 FARMING BASED PRODUCTION
10 GLOBAL STEVIOL GLYCOSIDE MARKET, BY CATEGORY, 2021-2030, (USD MILLION) (MILLION UNITS)
10.1 OVERVIEW
10.2 ORGANIC
10.3 CONVENTIONAL
11 GLOBAL STEVIOL GLYCOSIDE MARKET, BY APPLICATION, 2021-2030, (USD MILLION)
11.1 OVERVIEW
11.2 FOOD
11.2.1 FOOD, BY PRODUCT TYPE
11.2.1.1. STEVIOLBIOSIDE
11.2.1.2. DULCOSIDE A
11.2.1.3. STEVIOSIDE
11.2.1.4. REBAUDIOSIDE A
11.2.1.5. REBAUDIOSIDE B
11.2.1.6. REBAUDIOSIDE C
11.2.1.7. REBAUDIOSIDE D
11.2.1.8. REBAUDIOSIDE F
11.2.1.9. OTHERS
11.3 BEVERAGE
11.3.1 BEVERAGE, BY PRODUCT TYPE
11.3.1.1. STEVIOLBIOSIDE
11.3.1.2. DULCOSIDE A
11.3.1.3. STEVIOSIDE
11.3.1.4. REBAUDIOSIDE A
11.3.1.5. REBAUDIOSIDE B
11.3.1.6. REBAUDIOSIDE C
11.3.1.7. REBAUDIOSIDE D
11.3.1.8. REBAUDIOSIDE F
11.3.1.9. OTHERS
11.4 PHARMA & HEALTHCARE
11.4.1 PHARMA & HEALTHCARE, BY PRODUCT TYPE
11.4.1.1. STEVIOLBIOSIDE
11.4.1.2. DULCOSIDE A
11.4.1.3. STEVIOSIDE
11.4.1.4. REBAUDIOSIDE A
11.4.1.5. REBAUDIOSIDE B
11.4.1.6. REBAUDIOSIDE C
11.4.1.7. REBAUDIOSIDE D
11.4.1.8. REBAUDIOSIDE F
11.4.1.9. OTHERS
11.5 OTHERS
12 GLOBAL STEVIOL GLYCOSIDE MARKET, BY REGION, (2021-2030) (USD MILLION) (MILLION UNITS)
12.1 GLOBAL STEVIOL GLYCOSIDE MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
12.2 NORTH AMERICA
12.2.1 U.S.
12.2.2 CANADA
12.2.3 MEXICO
12.3 EUROPE
12.3.1 GERMANY
12.3.2 U.K.
12.3.3 ITALY
12.3.4 FRANCE
12.3.5 SPAIN
12.3.6 RUSSIA
12.3.7 SWITZERLAND
12.3.8 TURKEY
12.3.9 BELGIUM
12.3.10 NETHERLANDS
12.3.11 LUXEMBURG
12.3.12 REST OF EUROPE
12.4 ASIA-PACIFIC
12.4.1 JAPAN
12.4.2 CHINA
12.4.3 SOUTH KOREA
12.4.4 INDIA
12.4.5 SINGAPORE
12.4.6 THAILAND
12.4.7 INDONESIA
12.4.8 MALAYSIA
12.4.9 PHILIPPINES
12.4.10 AUSTRALIA & NEW ZEALAND
12.4.11 REST OF ASIA-PACIFIC
12.5 SOUTH AMERICA
12.5.1 BRAZIL
12.5.2 ARGENTINA
12.5.3 REST OF SOUTH AMERICA
12.6 MIDDLE EAST AND AFRICA
12.6.1 SOUTH AFRICA
12.6.2 EGYPT
12.6.3 SAUDI ARABIA
12.6.4 UNITED ARAB EMIRATES
12.6.5 ISRAEL
12.6.6 REST OF MIDDLE EAST AND AFRICA
13 GLOBAL STEVIOL GLYCOSIDE MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3 COMPANY SHARE ANALYSIS: EUROPE
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13.5 MERGERS AND ACQUISITIONS
13.6 NEW PRODUCT DEVELOPMENT AND APPROVALS
13.7 EXPANSIONS
13.8 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
14 GLOBAL STEVIOL GLYCOSIDE MARKET - COMPANY PROFILE
14.1 CARGILL, INCORPORATED
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCTION CAPACITY OVERVIEW
14.1.4 SWOT ANALYSIS
14.1.5 PRODUCT PORTFOLIO
14.2 INGREDION (PURECIRCLE)
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCTION CAPACITY OVERVIEW
14.2.4 SWOT ANALYSIS
14.2.5 PRODUCT PORTFOLIO
14.3 TATE & LYLE
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCTION CAPACITY OVERVIEW
14.3.4 SWOT ANALYSIS
14.3.5 PRODUCT PORTFOLIO
14.4 MORITA KAGAKU KOGYO CO., LTD
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCTION CAPACITY OVERVIEW
14.4.4 SWOT ANALYSIS
14.4.5 PRODUCT PORTFOLIO
14.5 GLG LIFE TECH CORP + ADM
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 PRODUCTION CAPACITY OVERVIEW
14.5.4 SWOT ANALYSIS
14.5.5 PRODUCT PORTFOLIO
14.6 SWEEGEN
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCTION CAPACITY OVERVIEW
14.6.4 SWOT ANALYSIS
14.6.5 PRODUCT PORTFOLIO
14.7 DSM
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCTION CAPACITY OVERVIEW
14.7.4 SWOT ANALYSIS
14.7.5 PRODUCT PORTFOLIO
14.8 LAYN CORP.
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCTION CAPACITY OVERVIEW
14.8.4 SWOT ANALYSIS
14.8.5 PRODUCT PORTFOLIO
14.9 DAEPYUNG CO., LTD
14.9.1 COMPANY SNAPSHOT
14.9.2 REVENUE ANALYSIS
14.9.3 PRODUCTION CAPACITY OVERVIEW
14.9.4 SWOT ANALYSIS
14.9.5 PRODUCT PORTFOLIO
14.1 GL STEVIA
14.10.1 COMPANY SNAPSHOT
14.10.2 REVENUE ANALYSIS
14.10.3 PRODUCTION CAPACITY OVERVIEW
14.10.4 SWOT ANALYSIS
14.10.5 PRODUCT PORTFOLIO
14.11 STEVIA GROUP
14.11.1 COMPANY SNAPSHOT
14.11.2 REVENUE ANALYSIS
14.11.3 PRODUCTION CAPACITY OVERVIEW
14.11.4 SWOT ANALYSIS
14.11.5 PRODUCT PORTFOLIO
14.12 SHANDONG HAIGEN BIOTECHNOLOGY CO.,LTD
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCTION CAPACITY OVERVIEW
14.12.4 SWOT ANALYSIS
14.12.5 PRODUCT PORTFOLIO
14.13 ZHUCHENG HAOTIAN PHARM CO., LTD. (HOWTIAN)
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCTION CAPACITY OVERVIEW
14.13.4 SWOT ANALYSIS
14.13.5 PRODUCT PORTFOLIO
14.14 SUNWIN STEVIA INTERNATIONAL INC
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCTION CAPACITY OVERVIEW
14.14.4 SWOT ANALYSIS
14.14.5 PRODUCT PORTFOLIO
14.15 HERBOVEDA
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCTION CAPACITY OVERVIEW
14.15.4 SWOT ANALYSIS
14.15.5 PRODUCT PORTFOLIO
15 QUESTIONNAIRE
16 RELATED REPORTS
17 ABOUT DATA BRIDGE MARKET RESEARCH
